These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21968268)

  • 1. Correlation of new bone metabolic markers with conventional biomarkers in hemodialysis patients.
    Takano M; Okano K; Tsuruta Y; Yamashita T; Echida Y; Miwa N; Kimata N; Akiba T; Nitta K
    Clin Invest Med; 2011 Oct; 34(5):E267. PubMed ID: 21968268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients.
    Maeno Y; Inaba M; Okuno S; Yamakawa T; Ishimura E; Nishizawa Y
    Clin Chem; 2005 Dec; 51(12):2312-7. PubMed ID: 16223890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis.
    Nagata Y; Inaba M; Imanishi Y; Okazaki H; Yamada S; Mori K; Shoji S; Koyama H; Okuno S
    Osteoporos Int; 2015 Mar; 26(3):1053-61. PubMed ID: 25403902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Yoshida H; Taniguchi M; Haruyama N; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.
    Shidara K; Inaba M; Okuno S; Yamada S; Kumeda Y; Imanishi Y; Yamakawa T; Ishimura E; Nishizawa Y
    Calcif Tissue Int; 2008 Apr; 82(4):278-87. PubMed ID: 18421493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.
    Ueda M; Inaba M; Okuno S; Nagasue K; Kitatani K; Ishimura E; Shimizu M; Miki T; Kim M; Nishizawa Y
    Am J Kidney Dis; 2002 Oct; 40(4):802-9. PubMed ID: 12324916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
    Doumouchtsis K; Perrea D; Doumouchtsis S; Tziamalis M; Poulakou M; Vlachos I; Kostakis A
    Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
    Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
    Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney transplantation restored uncoupled bone turnover in end-stage renal disease.
    Kawarazaki H; Shibagaki Y; Kido R; Nakajima I; Fuchinoue S; Ando K; Fujita T; Fukagawa M; Teraoka S; Fukumoto S
    Clin Nephrol; 2012 Jul; 78(1):10-6. PubMed ID: 22732332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alkaline Phosphatase, iPTH and Bone Turnover Markers in Chinese Advanced Chronic Kidney Disease Patients.
    Liu Y; He Q
    Clin Lab; 2015; 61(7):839-43. PubMed ID: 26299086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients.
    Ureña P; Ferreira A; Kung VT; Morieux C; Simon P; Ang KS; Souberbielle JC; Segre GV; Drüeke TB; De Vernejoul MC
    J Bone Miner Res; 1995 Jun; 10(6):932-9. PubMed ID: 7572317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure.
    Tsuchida T; Ishimura E; Miki T; Matsumoto N; Naka H; Jono S; Inaba M; Nishizawa Y
    Osteoporos Int; 2005 Feb; 16(2):172-9. PubMed ID: 15164161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.
    Ureña P; Hruby M; Ferreira A; Ang KS; de Vernejoul MC
    J Am Soc Nephrol; 1996 Mar; 7(3):506-12. PubMed ID: 8704118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients.
    Kobayashi I; Shidara K; Okuno S; Yamada S; Imanishi Y; Mori K; Ishimura E; Shoji S; Yamakawa T; Inaba M
    Life Sci; 2012 Jan; 90(5-6):212-8. PubMed ID: 22154904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineral-bone metabolism markers in young hemodialysis patients.
    Osorio A; Ortega E; Torres JM; Sanchez P; Ruiz-Requena E
    Clin Biochem; 2011 Dec; 44(17-18):1425-8. PubMed ID: 21933667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of new markers of bone formation and resorption in kidney transplant recipients.
    Małyszko J; Wołczyński S; Małyszko JS; Konstantynowicz J; Kaczmarski M; Myśliwiec M
    Transplant Proc; 2003 Jun; 35(4):1351-4. PubMed ID: 12826157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients.
    Nagasue K; Inaba M; Okuno S; Kitatani K; Imanishi Y; Ishimura E; Miki T; Kim M; Nishizawa Y
    Biomed Pharmacother; 2003 Mar; 57(2):98-104. PubMed ID: 12842495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between age-related biochemical markers of bone turnover and OPG, TGF-β1 and TGF-β2 in native Chinese women.
    Chen C; Liang MK; Zhang H; Peng YQ; Wu XP; Wu XY; Liao EY
    Endocr Res; 2014; 39(3):105-14. PubMed ID: 24152296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.